Thousands of HVADs could have faulty battery cells. Nancy Crotti HeartWare International is recalling more than 18,000 batteries for ventricular assist devices it sold between 2013 and 2015, the ...
Medtronic’s decision to stop selling its HeartWare ventricular assist device comes after a spate of Class I recalls for the blood pump linked to about a dozen deaths and more than 100 complaints.
Medtronic has stopped the sale of its Heartware Ventricular Assist Device (HVAD) system and is advising physicians cease implanting the device because problems with an internal pump can lead to death ...
In a letter to healthcare providers, the US Food and Drug Administration said today that Medtronic has ceased the sale and distribution of its HeartWare ventricular assist device (HVAD) system. The ...
Medtronic’s HeartWare Ventricular Assist Device, or HVAD system, was designed to be implanted in patients with severe heart failure to help pump blood from the heart to the rest of the body.
The U.S. Food and Drug Administration issued another Class 1 recall for Medtronic's HeartWare Ventricular Assist Device on Thursday, this time over the risk of battery failure. Medtronic said it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results